
|Slideshows|April 15, 2019
5 Myths About Biosimilars-And the Facts
Author(s)Nicholas Hamm
The falsehoods being spread about biosimilars that don’t match up with reality.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
PSG: Specialty drug spending predicted to increase 32% by 2028
2
Robyn Crosson, J.D., Navitus Health Solutions
3
CMS sets the 2027 Part D bid amount at $296.05, will end premium subsidy program
4
Lenacapavir made up 1% of U.S. PrEP use in the first six months of 2025, study finds | AIDS 2026
5






















